Effect of methylenetetrahydrofolate reductase C677T polymorphism on serum folate but not vitamin B12 levels in patients with H-type hypertension.

Ma, Lijuan; Li, Jing; Yuan, Yuan; Chen, Wenwen; Zhao, Jun

Ma, Lijuan; Li, Jing; Yuan, Yuan; Chen, Wenwen; Zhao, Jun.

Afiliación

Ma L; Department of Pharmacy, Xinjiang Medical University Affiliated First Hospital, Ürümqi, 830011, China.
Li J; The Precision Medicine Center of Xinjiang Medical University, Ürümqi, 830011, China.
Yuan Y; Department of Pharmacy, Xinjiang Medical University Affiliated First Hospital, Ürümqi, 830011, China.
Chen W; Department of Pharmacy, Xinjiang Medical University Affiliated First Hospital, Ürümqi, 830011, China.
Zhao J; The Precision Medicine Center of Xinjiang Medical University, Ürümqi, 830011, China.

Mol Biol Rep ; 49(10): 9535-9541, 2022 Oct.

Article en En | MEDLINE | ID: mdl-35951145

Asunto(s)

Hipertensión; Metilenotetrahidrofolato Reductasa (NADPH2); Antihipertensivos; Femenino; Ácido Fólico; Genotipo; Homocisteína; Humanos; Hipertensión/genética; Masculino; Metilenotetrahidrofolato Reductasa (NADPH2)/genética; Vitamina B 12

Palabras clave

Folate; H-type hypertension; Homocysteine; Methylenetetrahydrofolate reductase; Vitamin B12

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Metilenotetrahidrofolato Reductasa (NADPH2) / Hipertensión Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Mol Biol Rep Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google